Table 2.
Variables | |
---|---|
STAMPEDE | |
Risk = 0 | 58 (8.7%) |
Risk = 1 | 432 (64.5%) |
Risk = 2 | 142 (21.2%) |
Risk = 3 | 38 (5.6%) |
STAMPEDE risk factors | |
PSA level ≥ 40 ng/mL | 78 (11.6%) |
cT stage ≥ 3 | 300 (44.8%) |
Gleason score ≥ 8 | 452 (67.5%) |
PSA: prostate-specific antigen, STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate cancer.